fda warning glp-1 october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA issues 30 warning letters

Common clinical findings in these cases include: Persistent nausea and early satiety lasting weeks or months after discontinuation of the drug

ALCAR, thanks to its acetyl group, can cross the blood-brain barrier and additionally supports acetylcholine production, making it the preferred form for cognitive and brain-health goals

Peak pain occurred at 72 hours post-injection

Thyroid Cancer Risk There is a potential risk associated with thyroid cancer, particularly medullary thyroid carcinoma (MTC)

Sometimes preferred for peptides where the saline helps maintain pH stability

Novo Nordisk: Top Legal Representatives Novo Nordisks top legal representative was from Japan-based Sonoda & Kobayashi, followed by Murayama Yasuhiko of Shiga International Patent Office